Pharsight
Ask Pharsight
ONCOPEPTIDES AB PATENTS FACING OPPOSITIONS
Top patents of ONCOPEPTIDES AB facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3383385B2
06 Sep, 2023
Melflufen Dosage Regimens For Cancer
Dec, 2036
2